ArticleIntensive care medicine2026

A multicenter randomized, double-blinded placebo-controlled phase 2 trial to evaluate safety and efficacy of ilofotase alfa in patients at risk for kidney injury following open heart surgery.

Louis Mourisse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.